# SPANXN1

## Overview
SPANXN1 is a gene that encodes a member of the SPANX family of proteins, specifically SPANX family member N1, which is primarily involved in the process of spermatogenesis. The SPANX family proteins are categorized as cancer-testis antigens, which are typically expressed in the testis and various cancerous tissues. SPANXN1 is expressed predominantly in the later stages of sperm development, localizing to the acrosome in spermatozoa, and is detected in a significant majority of human spermatozoa, indicating its potential importance in sperm maturation and fertility (Kouprina2007Evolutionary). Despite its primary role in reproductive tissues, SPANXN1 is also expressed at low levels in several non-reproductive tissues and has been implicated in cancer diagnostics due to its expression in various malignancies (Kouprina2007Evolutionary). However, a frameshift mutation in SPANXN1 may render it non-functional, suggesting it could be a pseudogene (Kouprina2007Evolutionary).

## Function
The SPANXN1 gene encodes a protein that plays a significant role in spermatogenesis, particularly in the later stages of sperm development. SPANXN1 is part of the SPANX-N subfamily, which is expressed post-meiotically and localizes to the acrosome in spermatozoa, suggesting its involvement in sperm function and fertility (Kouprina2007Evolutionary). The SPANX-N proteins, including SPANXN1, are detected in over 90% of human spermatozoa, indicating a potentially essential role in sperm maturation and function (Kouprina2007Evolutionary).

SPANXN1 is expressed in late spermatids and spermatozoa within seminiferous tubules, supporting its role in the later stages of sperm development (Kouprina2007Evolutionary). Despite its primary expression in testicular tissue, SPANXN1 is also expressed at low levels in several nongametogenic adult tissues, suggesting a broader expression pattern (Kouprina2007Evolutionary). However, a frameshift mutation in exon 2 of SPANXN1 may render it non-functional, potentially classifying it as a pseudogene (Kouprina2007Evolutionary). Despite this, its expression in cancer cells suggests a possible role as a diagnostic marker for cancer (Kouprina2007Evolutionary).

## Clinical Significance
SPANXN1 has been studied for its potential role in cancer diagnostics due to its expression patterns in malignant tissues. It is predominantly expressed in testis but shows increased expression in various cancers, including melanoma, ovarian, endometrial, colorectal, prostate, lung, cervix, and breast cancers. This differential expression suggests that SPANXN1 could serve as a diagnostic marker for these cancers (Kouprina2007Evolutionary). Despite its expression in cancerous tissues, mutational analysis of SPANXN1 in families with hereditary prostate cancer did not find any genetic variants associated with increased susceptibility to X-linked prostate cancer (Kouprina2007Mutational).

The SPANX gene family, including SPANXN1, is part of the cancer-testis antigen group, which is often implicated in tumorigenesis. These antigens are expressed in various tumors and have been considered potential targets for cancer immunotherapy due to their restricted expression in normal tissues (Westbrook2004Genomic). However, SPANXN1 and SPANXN5 might be pseudogenes due to a frameshift mutation leading to a premature stop codon, which could result in nonsense-mediated mRNA decay, potentially affecting their functional roles in cancer (Kouprina2007Evolutionary).


## References


[1. (Kouprina2007Mutational) Natalay Kouprina, Vladimir N. Noskov, Greg Solomon, John Otstot, William Isaacs, Jianfeng Xu, Johanna Schleutker, and Vladimir Larionov. Mutational analysis ofspanxgenes in families with x‐linked prostate cancer. The Prostate, 67(8):820–828, March 2007. URL: http://dx.doi.org/10.1002/pros.20561, doi:10.1002/pros.20561. This article has 17 citations.](https://doi.org/10.1002/pros.20561)

[2. (Westbrook2004Genomic) V. Anne Westbrook, Pamela D. Schoppee, Alan B. Diekman, Kenneth L. Klotz, Margaretta Allietta, Kevin T. Hogan, Craig L. Slingluff, James W. Patterson, Henry F. Frierson, William P. Irvin, Charles J. Flickinger, Michael A. Coppola, and John C. Herr. Genomic organization, incidence, and localization of the span-x family of cancer-testis antigens in melanoma tumors and cell lines. Clinical Cancer Research, 10(1):101–112, January 2004. URL: http://dx.doi.org/10.1158/1078-0432.CCR-0647-3, doi:10.1158/1078-0432.ccr-0647-3. This article has 71 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1158/1078-0432.CCR-0647-3)

[3. (Kouprina2007Evolutionary) Natalay Kouprina, Vladimir N. Noskov, Adam Pavlicek, N. Keith Collins, Pamela D. Schoppee Bortz, Chris Ottolenghi, Dmitri Loukinov, Paul Goldsmith, John I. Risinger, Jung-Hyun Kim, V. Anne Westbrook, Gregory Solomon, Hanna Sounders, John C. Herr, Jerzy Jurka, Victor Lobanenkov, David Schlessinger, and Vladimir Larionov. Evolutionary diversification of spanx-n sperm protein gene structure and expression. PLoS ONE, 2(4):e359, April 2007. URL: http://dx.doi.org/10.1371/journal.pone.0000359, doi:10.1371/journal.pone.0000359. This article has 33 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0000359)